FIELD: skin care.
SUBSTANCE: composition for skin care contains low-molecular acetylated hyaluronic acid or its sodium salt, while low-molecular acetylated hyaluronic acid or its sodium salt has average molecular weight from 10 to 15 kDa, average acetylation degree of more than 3.8, and polydispersity indicator of less than 1.5. A method for the production of low-molecular acetylated hyaluronic acid, a method for the production of sodium salt of low-molecular acetylated hyaluronic acid, powder of low-molecular acetylated hyaluronic acid or its sodium salt for skin care, and a method for suppression of destruction of extracellular skin matrix associated with increased levels of matrix-destructing enzymes are also disclosed.
EFFECT: group of inventions provides treatment of visible aging effects on human skin.
15 cl, 1 dwg, 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GEL OF HYALURONIC ACID FOR INTRACUTANEOUS INJECTION | 2007 |
|
RU2448740C2 |
| COMBINATION OF HYALURONIC ACID AND SULPHATED POLYSACCHARIDE | 2015 |
|
RU2683567C2 |
| COMPOSITION OF MEDICINAL PRODUCT FOR STIMULATING HAIR GROWTH | 2023 |
|
RU2812523C1 |
| GEL COMPOSITION FOR SKIN TREATMENT | 2020 |
|
RU2753638C2 |
| COSMETIC COMPOSITION FOR HUMIDIFICATION AND SKIN PROTECTION | 2017 |
|
RU2660350C1 |
| HYDROGEL WATER-SOLUBLE COMPOSITION BASED ON HYALURONIC ACID AND POLYVALENT METAL IONS AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2710074C1 |
| CARNOSINE-HYALURONIC ACID MIXTURES AND THEIR USE | 2011 |
|
RU2602297C2 |
| INJECTED MEDICAL COMPOSITION | 2021 |
|
RU2788726C1 |
| SKINCARE TONIC | 2020 |
|
RU2755201C1 |
| AGING REDUCER AND EXPRESSION REGULATOR OF THE AGING DELAY-ASSOCIATED GENE | 2019 |
|
RU2744251C1 |
